‘If you’re not cell-enabled, you’re not connected’
TAMPA, Fla. – Smart Meter’s iGlucose diabetes care solution has met stringent requirements for reimbursement under the Centers for Medicare and Medicaid Services’ new remote monitoring CPT code.
It all comes down to cellular technology, said Cliff McIntosh, CEO of Smart Meter.
“It’s our secret sauce,” he said.
The iGlucose system uses cell-enabled technology instead of Bluetooth, allowing for real-time transmission of glucose test results. The technology is always on and doesn’t require the pairing of devices or syncing of data.
CMS’s Remote Patient Monitoring CPT code requires that certain criteria must be met, including: results must transmit to the provider in real-time; there must be an active feedback loop to patients through text or email; health data is patient generated; and patient data is digitally stored.
“This is a really exciting time for us,” said McIntosh. “Our product allows providers to meet all the criteria for this reimbursement.”
Smart Meter shipped its first product in the first quarter of 2018, after receiving clearance from the U.S. Food and Drug Administration a year ago.
McIntosh said that Bluetooth technology can result in reduced patient compliance because patient gets frustrated trying to connect and give up. The delay in data transmission with Bluetooth can also create problems if test results aren’t delivered to a patient’s provider in a timely manner.
Smart Meter will start looking for ways to leverage actionable data for better outcomes in the coming year, McIntosh said.
“We don’t need much bandwidth and we won’t become obsolete,” he said. “We think if you’re not cell-enabled, you’re not connected.”